Kura Oncology (KURA) Change in Acquisitions & Divestments: 2015-2024
Historic Change in Acquisitions & Divestments for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $557.9 million.
- Kura Oncology's Change in Acquisitions & Divestments rose 119.12% to $235.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $723.6 million, marking a year-over-year change of. This contributed to the annual value of $557.9 million for FY2024, which is 31.11% up from last year.
- Kura Oncology's Change in Acquisitions & Divestments amounted to $557.9 million in FY2024, which was up 31.11% from $425.5 million recorded in FY2023.
- In the past 5 years, Kura Oncology's Change in Acquisitions & Divestments registered a high of $557.9 million during FY2024, and its lowest value of $223.2 million during FY2020.
- For the 3-year period, Kura Oncology's Change in Acquisitions & Divestments averaged around $429.1 million, with its median value being $425.5 million (2023).
- As far as peak fluctuations go, Kura Oncology's Change in Acquisitions & Divestments spiked by 43.36% in 2021, and later dropped by 5.02% in 2022.
- Over the past 5 years, Kura Oncology's Change in Acquisitions & Divestments (Yearly) stood at $223.2 million in 2020, then spiked by 43.36% to $320.0 million in 2021, then dropped by 5.02% to $303.9 million in 2022, then skyrocketed by 40.03% to $425.5 million in 2023, then soared by 31.11% to $557.9 million in 2024.